Searched for
MANCHANDA
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Zappfresh in talks for majority stake in GM FoodsZappfresh is in discussions to acquire a majority stake in GM Foods. This move aims to expand Zappfresh's product offerings. The company is...
- Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...
- Mounjaro sales dip amid price war as semaglutide generics gain groundMounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...
- JSA strengthens corporate practice with senior lateral hires from CMS IndusLawThree equity partners from CMS IndusLaw, Siddharth Manchanda, Rashi Saraf, and Minhaz Lokhandwala, are moving to JSA Advocates & Solicitors...
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
- US FDA review boosts odds for Wockhardt’s NCE success story: Vishal ManchandaWockhardt’s breakthrough respiratory drug Zaynich moves a step closer to market as the US FDA accepts it for review, boosting approval odds...
- Don’t call Taarak Mehta Ka Ooltah Chashmah actor Lalit Manchanda’s death another suicide: TV artists urge UP CM Yogi Adityanath for high-level probeLalit Manchanda, recognized for his roles in 'Taarak Mehta Ka Ooltah Chashmah' and 'Crime Patrol,' was found dead at his Meerut residence, ...
- Taarak Mehta Ka Ooltah Chashmah actor Lalit Manchanda found dead in Meerut, police suspect suicide linked to stressActor Lalit Manchanda, known for his roles in Bollywood and television, was found dead at his Meerut home on Monday, April 21, in a suspect...
- FY27 may be a bit difficult for pharma companies due to US effect; betting on 2 stocks: Vishal ManchandaVishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs and weak US bu...
- Omnichannel meat retailer Zappfresh raises $4.3 million from Heifer Impact CapitalThe round also saw participation from publisher Hindustan Media Ventures, venture firm Ah! Ventures, and Unity SFB. Zappfresh founder and c...
- Normally Q2 is the highest quarter both in terms of revenue as well as volume: Om Prakash Manchanda, Whole-time Director & CEO, Dr Lal Pathlabs LtdIn an interview with ET Now, Om Prakash Manchanda, Whole-time Director & CEO, Dr Lal Pathlabs Ltd, gives his views on the company's Q2 resu...
- Diagnostic sector is growing at 17% & we continue to see same momentum: Om Manchanda, CEO, Dr Lal PathLabsIn an exclusive interaction with ET NOW, Om Manchanda, CEO, Dr Lal PathLabs talks about how diagnostic as a sector has got created in last ...
- Shocked by Mudgal report but will take stern steps: DDCADDCA treasurer Ravinder Manchanda promised to "take stern action" against those found guilty of indulging in malpractices.
- DDCA mulling legal action against Kirti Azad: Treasurer ManchandaDelhi & Districts Cricket Association (DDCA) treasurer Ravinder Manchanda today said they are mulling legal recourse against BJP MP Kirti A...
- Ethnic Indian to head Malaysian integrated steel millA Singapore banker of Indian origin Ravi Manchanda has taken charge as executive chairman of Malaysia's biggest steel group.
- Dr Lal Path Labs eying revenues of Rs 350 cr in FY12Dr Lal Path Labs, which operates Asia's largest diagnostics centre in the capital, runs 70 laboratories across the country.
Load More
